Section II
5851 – 5860 of 8749
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease
(
- Contribution to journal › Article
-
Mark
Involvement of calcium-calmodulin dependent protein kinase II on endothelin receptor expression in cerebral arteries of rat
2009) 24th International Symposium on Cerebral Blood Flow and Metabolism/9th International Conference on Quantification of Brain Function with PET In Journal of Cerebral Blood Flow and Metabolism 29. p.123-123(
- Contribution to journal › Published meeting abstract
-
Mark
Budesonide/formoterol maintenance and reliever therapy - lower corticosteroid load in the treatment of asthma in adolescents
2009) 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology In Allergy 64. p.156-156(
- Contribution to journal › Published meeting abstract
-
Mark
Associations Between Human Leukocyte Antigen (HLA) Genotype And Acute Myocardial Infarction
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.953-953(
- Contribution to journal › Published meeting abstract
-
Mark
Moderate mitral regurgitation in patients undergoing CABG - the MoMIC trial
(
- Contribution to journal › Article
-
Mark
Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation
(
- Contribution to journal › Article
-
Mark
Requiem for BK virus nephropathy (BKN) - three-year experience of systematic screening
(
- Contribution to journal › Published meeting abstract
-
Mark
Infections as a stimulus for coronary occlusion, obstruction, or acute coronary syndromes.
2009) In Therapeutic Advances in Cardiovascular Disease(
- Contribution to journal › Article
-
Mark
Heart failure exacerbation leading to hospital admission: a cross-sectional study
(
- Contribution to journal › Article
-
Mark
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists
(
- Contribution to journal › Article